dbACP: A Comprehensive Database of Anti-Cancer Peptides

9 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp05943 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay SW-1116 Colorectal cancer 72.69 Inhibition ratio at 50 µg/ml
dbacp05944 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay SMMC-7721 Liver cancer 70.39 Inhibition ratio at 50 µg/ml
dbacp05945 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HeLa Cervical cancer 73.09 Inhibition ratio at 50 µg/ml
dbacp05946 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HepG-2 Liver cancer 60.22 Inhibition ratio at 50 µg/ml
dbacp05947 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay BGC-823 Gastric cancer 62.49 Inhibition ratio at 50 µg/ml
dbacp05948 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay A-549 Lung cancer 47.26Inhibition ratio at 50 µg/ml
dbacp05949 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HL7702 Liver cancer 36.25 Inhibition ratio at 50 µg/ml
dbacp05950 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay HEK-293T Renal cancer 27.86 Inhibition ratio at 50 µg/ml
dbacp05951 RGD-La RGDLLRHVVKILEKYL Arg-Gly-Asp(RGD) tripeptide ana temporins Cell membrane disintegration MTT/MTS assay MEC Breast cancer 19.76 Inhibition ratio at 50 µg/ml